Activation Capital names Paul Nolde board chair, succeeding Michael Rao after 17-year tenure

RICHMOND, Va. — Activation Capital announced the election of Paul Nolde as chair of its Authority Board on Sept. 29, 2026, succeeding Virginia Commonwealth University President Michael Rao after a 17-year tenure leading the board. The leadership transition at the Virginia Biotechnology Research Partnership Authority marks a shift at the top for the organization as it manages its life sciences and technology commercialization mandates in the mid-Atlantic region (PR Newswire).

Strategic Context

Activation Capital operates as the registered trade name for the Virginia Biotechnology Research Partnership Authority, a state-level entity focused on building innovation infrastructure and supporting high-growth enterprises. Over nearly two decades under Rao's governance, the authority expanded its footprint and institutional linkages across the state's research corridor, anchoring its operations alongside major academic and medical institutions.

The appointment of Nolde to the chairmanship brings new leadership to the board as the organization oversees its ongoing development initiatives and programmatic investments in regional biotechnology and deep-tech sectors. Board chairs in such authorities typically guide high-level capital allocation, stakeholder alignment between state government and private research entities, and long-term infrastructure planning.

Forward Outlook

Operators, regional allocators, and institutional partners will monitor how the board under Nolde directs Activation Capital's upcoming operational milestones and asset management strategies. The organization continues to serve as a key economic development conduit for Virginia's life sciences ecosystem, bridging public sector backing with private commercialization efforts.